{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:10:45Z","timestamp":1788826245337,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76046-w","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:47:00Z","timestamp":1786056420000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nuclear localization of the glutaminyl-tRNA synthetase QARS reveals its role in DNA damage response in ovarian cancer"],"prefix":"10.1038","volume":"17","author":[{"given":"Martina","family":"Serafini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Di Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2722-3071","authenticated-orcid":false,"given":"Yann","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5007-2964","authenticated-orcid":false,"given":"Lounes","family":"Djerroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2475-0275","authenticated-orcid":false,"given":"L\u00e9onie","family":"Dec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-9702","authenticated-orcid":false,"given":"Michael","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-6133","authenticated-orcid":false,"given":"Yann","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Marchesoni-Acland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9227-7474","authenticated-orcid":false,"given":"Manuel D.","family":"Diaz-Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5754-5771","authenticated-orcid":false,"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-7164","authenticated-orcid":false,"given":"St\u00e9phan","family":"Vagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-8842","authenticated-orcid":false,"given":"Damarys","family":"Loew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3049-4278","authenticated-orcid":false,"given":"Raphael","family":"Ceccaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-6989","authenticated-orcid":false,"given":"Fatima","family":"Mechta-Grigoriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-639X","authenticated-orcid":false,"given":"Virginie","family":"Mieulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"76046_CR1","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network*. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","DOI":"10.1038\/nature10166"},{"key":"76046_CR2","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/nm.2512","volume":"17","author":"B Mateescu","year":"2011","unstructured":"Mateescu, B. et al. MiR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat. Med. 17, 1627\u20131635 (2011).","journal-title":"Nat. Med."},{"key":"76046_CR3","doi-asserted-by":"publisher","first-page":"5454","DOI":"10.1158\/0008-5472.CAN-12-1470","volume":"72","author":"T Popova","year":"2012","unstructured":"Popova, T. et al. Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1\/2 inactivation. Cancer Res. 72, 5454\u20135462 (2012).","journal-title":"Cancer Res"},{"key":"76046_CR4","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.biocel.2013.03.001","volume":"45","author":"L Batista","year":"2013","unstructured":"Batista, L., Gruosso, T. & Mechta-Grigoriou, F. Ovarian cancer emerging subtypes: Role of oxidative stress and fibrosis in tumour development and response to treatment. Int. J. Biochem. Cell Biol. 45, 1092\u20131098 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"76046_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang, H. et al. Integrated proteogenomic characterization of human high-grade serous ovarian cancer. Cell 166, 755\u2013765 (2016).","journal-title":"Cell"},{"key":"76046_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cmet.2018.09.002","volume":"29","author":"G Gentric","year":"2019","unstructured":"Gentric, G. et al. PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab. 29, 156\u2013173.e110 (2019).","journal-title":"Cell Metab."},{"key":"76046_CR7","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/bjc.2012.451","volume":"107","author":"V Abkevich","year":"2012","unstructured":"Abkevich, V. et al. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer. Br. J. Cancer 107, 1776\u20131782 (2012).","journal-title":"Br. J. Cancer"},{"key":"76046_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/2159-8290.CD-11-0206","volume":"2","author":"NJ Birkbak","year":"2012","unstructured":"Birkbak, N. J. et al. Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents. Cancer Discov. 2, 366\u2013375 (2012).","journal-title":"Cancer Discov."},{"key":"76046_CR9","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","volume":"5","author":"PA Konstantinopoulos","year":"2015","unstructured":"Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I. & D\u2019Andrea, A. D. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 5, 1137\u20131154 (2015).","journal-title":"Cancer Discov."},{"key":"76046_CR10","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/s41416-018-0268-6","volume":"119","author":"JN Patel","year":"2018","unstructured":"Patel, J. N. et al. Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer. Br. J. Cancer 119, 1060\u20131066 (2018).","journal-title":"Br. J. Cancer"},{"key":"76046_CR11","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","volume":"11","author":"J Setton","year":"2021","unstructured":"Setton, J. et al. Synthetic lethality in cancer therapeutics: the next generation. Cancer Discov. 11, 1626\u20131635 (2021).","journal-title":"Cancer Discov."},{"key":"76046_CR12","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41571-018-0055-6","volume":"15","author":"A Ashworth","year":"2018","unstructured":"Ashworth, A. & Lord, C. J. Synthetic lethal therapies for cancer: what\u2019s next after PARP inhibitors? Nat. Rev. Clin. Oncol. 15, 564\u2013576 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"76046_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1089\/ars.2016.6750","volume":"26","author":"G Gentric","year":"2017","unstructured":"Gentric, G., Mieulet, V. & Mechta-Grigoriou, F. Heterogeneity in cancer metabolism: new concepts in an old field. Antioxid. Redox Signal. 26, 462\u2013485 (2017).","journal-title":"Antioxid. Redox Signal."},{"key":"76046_CR14","doi-asserted-by":"crossref","unstructured":"Fasoulakis, Z. et al. Ovarian cancer and glutamine metabolism. Int. J. Mol. Sci. 24, 5041 (2023).","DOI":"10.3390\/ijms24055041"},{"key":"76046_CR15","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1128\/MCB.21.10.3314-3324.2001","volume":"21","author":"JS Seeler","year":"2001","unstructured":"Seeler, J. S. et al. Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol. Cell Biol. 21, 3314\u20133324 (2001).","journal-title":"Mol. Cell Biol."},{"key":"76046_CR16","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1128\/MCB.25.7.2708-2721.2005","volume":"25","author":"WQ Jiang","year":"2005","unstructured":"Jiang, W. Q. et al. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11\/RAD50\/NBS1 complex. Mol. Cell Biol. 25, 2708\u20132721 (2005).","journal-title":"Mol. Cell Biol."},{"key":"76046_CR17","doi-asserted-by":"publisher","first-page":"11890","DOI":"10.1093\/nar\/gkaa828","volume":"48","author":"A Corpet","year":"2020","unstructured":"Corpet, A. et al. PML nuclear bodies and chromatin dynamics: catch me if you can!. Nucleic Acids Res 48, 11890\u201311912 (2020).","journal-title":"Nucleic Acids Res"},{"key":"76046_CR18","doi-asserted-by":"publisher","first-page":"13587","DOI":"10.18632\/oncotarget.7277","volume":"7","author":"KC Strickland","year":"2016","unstructured":"Strickland, K. C. et al. Association and prognostic significance of BRCA1\/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1\/PD-L1 in high grade serous ovarian cancer. Oncotarget 7, 13587\u201313598 (2016).","journal-title":"Oncotarget"},{"key":"76046_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.648687","volume":"11","author":"W Sun","year":"2021","unstructured":"Sun, W. et al. Targeting DNA damage repair for immune checkpoint inhibition: mechanisms and potential clinical applications. Front Oncol. 11, 648687 (2021).","journal-title":"Front Oncol."},{"key":"76046_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I Vazquez-Garcia","year":"2022","unstructured":"Vazquez-Garcia, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","journal-title":"Nature"},{"key":"76046_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28389-3","volume":"13","author":"IM Launonen","year":"2022","unstructured":"Launonen, I. M. et al. Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer. Nat. Commun. 13, 835 (2022).","journal-title":"Nat. Commun."},{"key":"76046_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211039899","volume":"13","author":"A Leary","year":"2021","unstructured":"Leary, A., Tan, D. & Ledermann, J. Immune checkpoint inhibitors in ovarian cancer: where do we stand? Ther. Adv. Med Oncol. 13, 17588359211039899 (2021).","journal-title":"Ther. Adv. Med Oncol."},{"key":"76046_CR23","doi-asserted-by":"publisher","unstructured":"Ghisoni, E. et al. Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-024-00937-4 (2024).","DOI":"10.1038\/s41571-024-00937-4"},{"key":"76046_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03348-z","volume":"9","author":"AM Givel","year":"2018","unstructured":"Givel, A. M. et al. miR200-regulated CXCL12beta promotes fibroblast heterogeneity and immunosuppression in ovarian cancers. Nat. Commun. 9, 1056 (2018).","journal-title":"Nat. Commun."},{"key":"76046_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83685-0","volume":"11","author":"V Mieulet","year":"2021","unstructured":"Mieulet, V. et al. Stiffness increases with myofibroblast content and collagen density in mesenchymal high grade serous ovarian cancer. Sci. Rep. 11, 4219 (2021).","journal-title":"Sci. Rep."},{"key":"76046_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45595-3","volume":"15","author":"M Licaj","year":"2024","unstructured":"Licaj, M. et al. Residual ANTXR1+ myofibroblasts after chemotherapy inhibit anti-tumor immunity via YAP1 signaling pathway. Nat. Commun. 15, 1312 (2024).","journal-title":"Nat. Commun."},{"key":"76046_CR27","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1111\/febs.16321","volume":"289","author":"C Riepe","year":"2022","unstructured":"Riepe, C. et al. Double stranded DNA breaks and genome editing trigger loss of ribosomal protein RPS27A. FEBS J. 289, 3101\u20133114 (2022).","journal-title":"FEBS J."},{"key":"76046_CR28","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1111\/febs.16398","volume":"289","author":"MB Kathjoo","year":"2022","unstructured":"Kathjoo, M. B. & Srivastava, M. A link between DNA double-strand breaks and regulation of global translation. FEBS J. 289, 3093\u20133096 (2022).","journal-title":"FEBS J."},{"key":"76046_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2041-2","volume":"579","author":"Z Shao","year":"2020","unstructured":"Shao, Z. et al. DNA-PKcs has KU-dependent function in rRNA processing and haematopoiesis. Nature 579, 291\u2013296 (2020).","journal-title":"Nature"},{"key":"76046_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrc.2016.27","volume":"16","author":"ML Truitt","year":"2016","unstructured":"Truitt, M. L. & Ruggero, D. New frontiers in translational control of the cancer genome. Nat. Rev. Cancer 16, 288\u2013304 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"76046_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41568-021-00380-y","volume":"21","author":"L Fabbri","year":"2021","unstructured":"Fabbri, L., Chakraborty, A., Robert, C. & Vagner, S. The plasticity of mRNA translation during cancer progression and therapy resistance. Nat. Rev. Cancer 21, 558\u2013577 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"76046_CR32","unstructured":"Mieulet, V. & Mechta-Grigoriou, F. Co-inventors. MAP3K8 as a marker for selecting a patient affected with an ovarian cancer for a treatment with a MEK inhibitor. Patent European Publication Number EP14306434.3 (2014)."},{"key":"76046_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms9583","volume":"6","author":"T Gruosso","year":"2015","unstructured":"Gruosso, T. et al. MAP3K8\/TPL-2\/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas. Nat. Commun. 6, 1\u201315 (2015).","journal-title":"Nat. Commun."},{"key":"76046_CR34","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41591-019-0373-y","volume":"25","author":"S Newman","year":"2019","unstructured":"Newman, S. et al. Clinical genome sequencing uncovers potentially targetable truncations and fusions of MAP3K8 in spitzoid and other melanomas. Nat. Med 25, 597\u2013602 (2019).","journal-title":"Nat. Med"},{"key":"76046_CR35","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1158\/1541-7786.MCR-19-0257","volume":"17","author":"BD Lehmann","year":"2019","unstructured":"Lehmann, B. D. et al. Identification of targetable recurrent MAP3K8 rearrangements in melanomas lacking known driver mutations. Mol. Cancer Res 17, 1842\u20131853 (2019).","journal-title":"Mol. Cancer Res"},{"key":"76046_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrc3124","volume":"11","author":"S Kim","year":"2011","unstructured":"Kim, S., You, S. & Hwang, D. Aminoacyl-tRNA synthetases and tumorigenesis: more than housekeeping. Nat. Rev. Cancer 11, 708\u2013718 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"76046_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","volume":"18","author":"NH Kwon","year":"2019","unstructured":"Kwon, N. H., Fox, P. L. & Kim, S. Aminoacyl-tRNA synthetases as therapeutic targets. Nat. Rev. Drug Discov. 18, 629\u2013650 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"76046_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1261\/rna.071720.119","volume":"26","author":"MA Rubio Gomez","year":"2020","unstructured":"Rubio Gomez, M. A. & Ibba, M. Aminoacyl-tRNA synthetases. RNA 26, 910\u2013936 (2020).","journal-title":"RNA"},{"key":"76046_CR39","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1016\/j.molcel.2021.09.002","volume":"81","author":"J Champagne","year":"2021","unstructured":"Champagne, J. et al. Oncogene-dependent sloppiness in mRNA translation. Mol. Cell 81, 4709\u20134721.e4709 (2021).","journal-title":"Mol. Cell"},{"key":"76046_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41556-022-00856-5","volume":"24","author":"MC Passarelli","year":"2022","unstructured":"Passarelli, M. C. et al. Leucyl-tRNA synthetase is a tumour suppressor in breast cancer and regulates codon-dependent translation dynamics. Nat. Cell Biol. 24, 307\u2013315 (2022).","journal-title":"Nat. Cell Biol."},{"key":"76046_CR41","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","volume":"603","author":"A Pataskar","year":"2022","unstructured":"Pataskar, A. et al. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603, 721\u2013727 (2022).","journal-title":"Nature"},{"key":"76046_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-021-04244-1","volume":"601","author":"P Thandapani","year":"2022","unstructured":"Thandapani, P. et al. Valine tRNA levels and availability regulate complex I assembly in leukaemia. Nature 601, 428\u2013433 (2022).","journal-title":"Nature"},{"key":"76046_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.immuni.2022.04.017","volume":"55","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Leucine-tRNA-synthase-2-expressing B cells contribute to colorectal cancer immunoevasion. Immunity 55, 1067\u20131081.e1068 (2022).","journal-title":"Immunity"},{"key":"76046_CR44","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41556-024-01439-2","volume":"26","author":"N El-Hachem","year":"2024","unstructured":"El-Hachem, N. et al. Valine aminoacyl-tRNA synthetase promotes therapy resistance in melanoma. Nat. Cell Biol. 26, 1154\u20131164 (2024).","journal-title":"Nat. Cell Biol."},{"key":"76046_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmet.2017.10.015","volume":"27","author":"XD He","year":"2018","unstructured":"He, X. D. et al. Sensing and transmitting intracellular amino acid signals through reversible lysine aminoacylations. Cell Metab. 27, 151\u2013166.e156 (2018).","journal-title":"Cell Metab."},{"key":"76046_CR46","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1074\/jbc.REV118.002958","volume":"294","author":"DY Hyeon","year":"2019","unstructured":"Hyeon, D. Y. et al. Evolution of the multi-tRNA synthetase complex and its role in cancer. J. Biol. Chem. 294, 5340\u20135351 (2019).","journal-title":"J. Biol. Chem."},{"key":"76046_CR47","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0006-291X(02)02755-9","volume":"299","author":"K Naka","year":"2002","unstructured":"Naka, K., Ikeda, K. & Motoyama, N. Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem Biophys. Res Commun. 299, 863\u2013871 (2002).","journal-title":"Biochem Biophys. Res Commun."},{"key":"76046_CR48","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1016\/j.febslet.2010.07.029","volume":"584","author":"BJ Lamarche","year":"2010","unstructured":"Lamarche, B. J., Orazio, N. I. & Weitzman, M. D. The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett. 584, 3682\u20133695 (2010).","journal-title":"FEBS Lett."},{"key":"76046_CR49","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/sj.emboj.7601166","volume":"25","author":"D Shahbazian","year":"2006","unstructured":"Shahbazian, D. et al. The mTOR\/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity. EMBO J. 25, 2781\u20132791 (2006).","journal-title":"EMBO J."},{"key":"76046_CR50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1042\/BST20150126","volume":"43","author":"N Siddiqui","year":"2015","unstructured":"Siddiqui, N. & Sonenberg, N. Signalling to eIF4E in cancer. Biochem Soc. Trans. 43, 763\u2013772 (2015).","journal-title":"Biochem Soc. Trans."},{"key":"76046_CR51","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1016\/j.bmcl.2005.08.029","volume":"15","author":"LK Gavrin","year":"2005","unstructured":"Gavrin, L. K. et al. Inhibition of Tpl2 kinase and TNF-alpha production with 1,7-naphthyridine-3-carbonitriles: synthesis and structure-activity relationships. Bioorg. Med Chem. Lett. 15, 5288\u20135292 (2005).","journal-title":"Bioorg. Med Chem. Lett."},{"key":"76046_CR52","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/j.1460-2075.1996.tb00398.x","volume":"15","author":"L Beretta","year":"1996","unstructured":"Beretta, L., Gingras, A. C., Svitkin, Y. V., Hall, M. N. & Sonenberg, N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15, 658\u2013664 (1996).","journal-title":"EMBO J."},{"key":"76046_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw, R. J. & Cantley, L. C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424\u2013430 (2006).","journal-title":"Nature"},{"key":"76046_CR54","doi-asserted-by":"crossref","unstructured":"Roux, P. P. & Topisirovic, I. Signaling Pathways Involved in the Regulation of mRNA Translation. Mol. Cell Biol. 38, e00070-1 (2018).","DOI":"10.1128\/MCB.00070-18"},{"key":"76046_CR55","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/371762a0","volume":"371","author":"A Pause","year":"1994","unstructured":"Pause, A. et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5\u2019-cap function. Nature 371, 762\u2013767 (1994).","journal-title":"Nature"},{"key":"76046_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41586-025-08815-4","volume":"640","author":"J Fielden","year":"2025","unstructured":"Fielden, J. et al. Comprehensive interrogation of synthetic lethality in the DNA damage response. Nature 640, 1093\u20131102 (2025).","journal-title":"Nature"},{"key":"76046_CR57","doi-asserted-by":"crossref","unstructured":"Moon, J. et al. DNA damage and its role in cancer therapeutics. Int. J. Mol. Sci. 24, 4741 (2023).","DOI":"10.3390\/ijms24054741"},{"key":"76046_CR58","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dnarep.2004.08.010","volume":"4","author":"N Puget","year":"2005","unstructured":"Puget, N., Knowlton, M. & Scully, R. Molecular analysis of sister chromatid recombination in mammalian cells. DNA Repair (Amst.) 4, 149\u2013161 (2005).","journal-title":"DNA Repair (Amst.)"},{"key":"76046_CR59","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.1038\/sj.onc.1209344","volume":"25","author":"A Dumay","year":"2006","unstructured":"Dumay, A. et al. Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation. Oncogene 25, 3196\u20133205 (2006).","journal-title":"Oncogene"},{"key":"76046_CR60","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nsmb.1641","volume":"16","author":"E Rass","year":"2009","unstructured":"Rass, E. et al. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat. Struct. Mol. Biol. 16, 819\u2013824 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"76046_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrm805","volume":"3","author":"D D\u2019Amours","year":"2002","unstructured":"D\u2019Amours, D. & Jackson, S. P. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3, 317\u2013327 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"76046_CR62","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41580-025-00841-4","volume":"26","author":"R Ceccaldi","year":"2025","unstructured":"Ceccaldi, R. & Cejka, P. Mechanisms and regulation of DNA end resection in the maintenance of genome stability. Nat. Rev. Mol. Cell Biol. 26, 586\u2013599 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"76046_CR63","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"BC Blount","year":"1997","unstructured":"Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA 94, 3290\u20133295 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76046_CR64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/nar\/gkn910","volume":"37","author":"PM Wilson","year":"2009","unstructured":"Wilson, P. M., Fazzone, W., LaBonte, M. J., Lenz, H. J. & Ladner, R. D. Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage. Nucleic Acids Res 37, 78\u201395 (2009).","journal-title":"Nucleic Acids Res"},{"key":"76046_CR65","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cas.14718","volume":"112","author":"T Yokogawa","year":"2021","unstructured":"Yokogawa, T. et al. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells. Cancer Sci. 112, 422\u2013432 (2021).","journal-title":"Cancer Sci."},{"key":"76046_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215898","volume":"548","author":"M Xu","year":"2022","unstructured":"Xu, M. et al. Overexpression of nucleotide metabolic enzyme DUT in hepatocellular carcinoma potentiates a therapeutic opportunity through targeting its dUTPase activity. Cancer Lett. 548, 215898 (2022).","journal-title":"Cancer Lett."},{"key":"76046_CR67","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.molcel.2025.01.031","volume":"85","author":"D Musiani","year":"2025","unstructured":"Musiani, D. et al. Uracil processing by SMUG1 in the absence of UNG triggers homologous recombination and selectively kills BRCA1\/2-deficient tumors. Mol. Cell 85, 1072\u20131084.e1010 (2025).","journal-title":"Mol. Cell"},{"key":"76046_CR68","first-page":"99","volume":"809","author":"HR Chang","year":"2018","unstructured":"Chang, H. R. et al. The functional roles of PML nuclear bodies in genome maintenance. Mutat. Res 809, 99\u2013107 (2018).","journal-title":"Mutat. Res"},{"key":"76046_CR69","doi-asserted-by":"publisher","first-page":"29314","DOI":"10.1074\/jbc.M701413200","volume":"282","author":"ZH Zhong","year":"2007","unstructured":"Zhong, Z. H. et al. Disruption of telomere maintenance by depletion of the MRE11\/RAD50\/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem. 282, 29314\u201329322 (2007).","journal-title":"J. Biol. Chem."},{"key":"76046_CR70","first-page":"2331","volume":"60","author":"DB Lombard","year":"2000","unstructured":"Lombard, D. B. & Guarente, L. Nijmegen breakage syndrome disease protein and MRE11 at PML nuclear bodies and meiotic telomeres. Cancer Res 60, 2331\u20132334 (2000).","journal-title":"Cancer Res"},{"key":"76046_CR71","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200060","volume":"6","author":"JJ Lee","year":"2022","unstructured":"Lee, J. J. et al. Unraveling the transcriptomic signatures of homologous recombination deficiency in ovarian cancers. Adv. Biol. (Weinh.) 6, e2200060 (2022).","journal-title":"Adv. Biol. (Weinh.)"},{"key":"76046_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00519-8","volume":"8","author":"NW Bateman","year":"2024","unstructured":"Bateman, N. W. et al. Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities. NPJ Precis Oncol. 8, 68 (2024).","journal-title":"NPJ Precis Oncol."},{"key":"76046_CR73","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1083\/jcb.149.3.567","volume":"149","author":"YG Ko","year":"2000","unstructured":"Ko, Y. G., Kang, Y. S., Kim, E. K., Park, S. G. & Kim, S. Nucleolar localization of human methionyl-tRNA synthetase and its role in ribosomal RNA synthesis. J. Cell Biol. 149, 567\u2013574 (2000).","journal-title":"J. Cell Biol."},{"key":"76046_CR74","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.108.191189","volume":"104","author":"H Fukui","year":"2009","unstructured":"Fukui, H., Hanaoka, R. & Kawahara, A. Noncanonical activity of seryl-tRNA synthetase is involved in vascular development. Circ. Res 104, 1253\u20131259 (2009).","journal-title":"Circ. Res"},{"key":"76046_CR75","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.108.191718","volume":"104","author":"W Herzog","year":"2009","unstructured":"Herzog, W., Muller, K., Huisken, J. & Stainier, D. Y. Genetic evidence for a noncanonical function of seryl-tRNA synthetase in vascular development. Circ. Res 104, 1260\u20131266 (2009).","journal-title":"Circ. Res"},{"key":"76046_CR76","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.molcel.2009.05.019","volume":"34","author":"N Yannay-Cohen","year":"2009","unstructured":"Yannay-Cohen, N. et al. LysRS serves as a key signaling molecule in the immune response by regulating gene expression. Mol. Cell 34, 603\u2013611 (2009).","journal-title":"Mol. Cell"},{"key":"76046_CR77","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nchembio.937","volume":"8","author":"M Sajish","year":"2012","unstructured":"Sajish, M. et al. Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-gamma and p53 signaling. Nat. Chem. Biol. 8, 547\u2013554 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"76046_CR78","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2014.09.006","volume":"56","author":"N Wei","year":"2014","unstructured":"Wei, N. et al. Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. Mol. Cell 56, 323\u2013332 (2014).","journal-title":"Mol. Cell"},{"key":"76046_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112400","volume":"42","author":"R Zhao","year":"2023","unstructured":"Zhao, R. et al. Nuclear ATR lysine-tyrosylation protects against heart failure by activating DNA damage response. Cell Rep. 42, 112400 (2023).","journal-title":"Cell Rep."},{"key":"76046_CR80","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1074\/jbc.M006189200","volume":"276","author":"YG Ko","year":"2001","unstructured":"Ko, Y. G. et al. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J. Biol. Chem. 276, 6030\u20136036 (2001).","journal-title":"J. Biol. Chem."},{"key":"76046_CR81","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/bies.20089","volume":"26","author":"G Dellaire","year":"2004","unstructured":"Dellaire, G. & Bazett-Jones, D. P. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26, 963\u2013977 (2004).","journal-title":"Bioessays"},{"key":"76046_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmet.2017.12.012","volume":"27","author":"SM Jafarnejad","year":"2018","unstructured":"Jafarnejad, S. M., Kim, S. H. & Sonenberg, N. Aminoacylation of proteins: new targets for the old ARSenal. Cell Metab. 27, 1\u20133 (2018).","journal-title":"Cell Metab."},{"key":"76046_CR83","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","volume":"631","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. NBS1 lactylation is required for efficient DNA repair and chemotherapy resistance. Nature 631, 663\u2013669 (2024).","journal-title":"Nature"},{"key":"76046_CR84","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","volume":"187","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Metabolic regulation of homologous recombination repair by MRE11 lactylation. Cell 187, 294\u2013311.e221 (2024).","journal-title":"Cell"},{"key":"76046_CR85","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2018.03.011","volume":"52","author":"V Lallemand-Breitenbach","year":"2018","unstructured":"Lallemand-Breitenbach, V. & de The, H. PML nuclear bodies: from architecture to function. Curr. Opin. Cell Biol. 52, 154\u2013161 (2018).","journal-title":"Curr. Opin. Cell Biol."},{"key":"76046_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1083\/jcb.200604009","volume":"175","author":"G Dellaire","year":"2006","unstructured":"Dellaire, G. et al. Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose response to DNA double-strand breaks is regulated by NBS1 and the kinases ATM, Chk2, and ATR. J. Cell Biol. 175, 55\u201366 (2006).","journal-title":"J. Cell Biol."},{"key":"76046_CR87","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/jcb.24050","volume":"113","author":"PL Yeung","year":"2012","unstructured":"Yeung, P. L. et al. Promyelocytic leukemia nuclear bodies support a late step in DNA double-strand break repair by homologous recombination. J. Cell Biochem 113, 1787\u20131799 (2012).","journal-title":"J. Cell Biochem"},{"key":"76046_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.115","volume":"7","author":"A di Masi","year":"2016","unstructured":"di Masi, A. et al. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL. Cell Death Dis. 7, e2308 (2016).","journal-title":"Cell Death Dis."},{"key":"76046_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05491-4","volume":"13","author":"AM Cobb","year":"2022","unstructured":"Cobb, A. M. et al. Filamentous nuclear actin regulation of PML NBs during the DNA damage response is deregulated by prelamin A. Cell Death Dis. 13, 1042 (2022).","journal-title":"Cell Death Dis."},{"key":"76046_CR90","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature01125","volume":"420","author":"H Tauchi","year":"2002","unstructured":"Tauchi, H. et al. Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature 420, 93\u201398 (2002).","journal-title":"Nature"},{"key":"76046_CR91","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1128\/MCB.17.10.6087","volume":"17","author":"RS Maser","year":"1997","unstructured":"Maser, R. S., Monsen, K. J., Nelms, B. E. & Petrini, J. H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell Biol. 17, 6087\u20136096 (1997).","journal-title":"Mol. Cell Biol."},{"key":"76046_CR92","doi-asserted-by":"publisher","unstructured":"Meijer, T. G. et al. Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1\/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers16040741 (2024).","DOI":"10.3390\/cancers16040741"},{"key":"76046_CR93","doi-asserted-by":"publisher","unstructured":"Lefort, S. et al. Inhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancers. Autophagy https:\/\/doi.org\/10.4161\/15548627.2014.981788 (2014).","DOI":"10.4161\/15548627.2014.981788"},{"key":"76046_CR94","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13572","volume":"513","author":"L Boussemart","year":"2014","unstructured":"Boussemart, L. et al. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature 513, 105\u2013109 (2014).","journal-title":"Nature"},{"key":"76046_CR95","doi-asserted-by":"publisher","unstructured":"Cerezo, M. et al. Translational control of tumor immune escape via the eIF4F\u2013STAT1\u2013PD-L1 axis in melanoma. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-018-0217-1 (2018).","DOI":"10.1038\/s41591-018-0217-1"},{"key":"76046_CR96","doi-asserted-by":"crossref","unstructured":"Ernlund, A. W., Schneider, R. J. & Ruggles, K. V. RIVET: comprehensive graphic user interface for analysis and exploration of genome-wide translatomics data. BMC Genomics, 8, 809 (2018).","DOI":"10.1186\/s12864-018-5166-z"},{"key":"76046_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"76046_CR98","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.molcel.2004.05.008","volume":"14","author":"J Guirouilh-Barbat","year":"2004","unstructured":"Guirouilh-Barbat, J. et al. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol. Cell 14, 611\u2013623 (2004).","journal-title":"Mol. Cell"},{"key":"76046_CR99","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1002\/pmic.200600784","volume":"7","author":"P Poullet","year":"2007","unstructured":"Poullet, P., Carpentier, S. & Barillot, E. myProMS, a web server for management and validation of mass spectrometry-based proteomic data. Proteomics 7, 2553\u20132556 (2007).","journal-title":"Proteomics"},{"key":"76046_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek, D., Morris, J. H., Boucas, J., Pico, A. R. & Demchak, B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 20, 185 (2019).","journal-title":"Genome Biol."},{"key":"76046_CR101","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkae1011","volume":"53","author":"Y Perez-Riverol","year":"2025","unstructured":"Perez-Riverol, Y. et al. The PRIDE database at 20 years: 2025 update. Nucleic Acids Res 53, D543\u2013D553 (2025).","journal-title":"Nucleic Acids Res"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76046-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76046-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76046-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:03:52Z","timestamp":1788825832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76046-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76046"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76046-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.M.-G. received research support from Roche and Institut Roche. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9590"}}